Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$667K Buy
15,017
+1,694
+13% +$81.1K ﹤0.01% 4002
2014
Q2
$684K Buy
13,323
+5,558
+72% +$279K ﹤0.01% 3915
2014
Q1
$407K Sell
7,765
-905
-10% -$45.3K ﹤0.01% 4464
2013
Q4
$433K Sell
8,670
-5,285
-38% -$262K ﹤0.01% 4491
2013
Q3
$674K Buy
13,955
+7,338
+111% +$366K ﹤0.01% 3783
2013
Q2
$330K Buy
+6,617
New +$327K ﹤0.01% 4539

Other funds holding ALE

UBS's ALE Position: Q3 2014 in Review

UBS increased its Allete (ALE) stake by 13% in Q3 2014, buying an estimated $81.1K and bringing the position to 15,017 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #4002.

UBS first reported a position in ALE in Q2 2013 and has held it in 6 quarters since. The position peaked at $684K in Q2 2014. 196 funds tracked by Wall St. Rank hold ALE as of Q3 2014.

  • UBS held 15,017 shares of Allete worth $667K as of Q3 2014.
  • UBS bought 1,694 Allete shares in Q3 2014, an estimated $81.1K.
  • Allete made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4002 holding.
  • UBS first reported a position in Allete in Q2 2013 and has held it in 6 quarters since.
  • UBS's Allete position peaked at $684K in Q2 2014.
  • 196 funds tracked by Wall St. Rank held Allete as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.